It is widely believed that the loss of transforming growth factor-beta- receptors (TGF-beta- R) contributes significantly to carcinogenesis. Functional TGF-beta-R comprise several gene products, including two essential signaling components, the type I TGF-beta-R and the type II TGF-beta-R (TbetaR-II). In several instances in which tumor cells fail to express the TbetaR-II gene at the RNA or protein level, no apparent structural mutations within the coding region of the gene have been observed. This suggests that defects in the promoter region of the TbetaR-II gene and/or in the mechanisms regulating the transcription of the TbetaR-II gene play key roles in its aberrant expression in certain neoplasms. Thus, Dr. Rizzino feels that it is important to understand how the TbetaR-II gene is regulated. Before attempting to understand why this gene is expressed aberrantly in tumor cells, it is important to understand how this gene is regulated normally. Embryonal carcinoma (EC) cells are well suited to achieving this objective, since the differentiation of these cells leads to the turn on of TGF-beta-R. Efforts to understand how the TbetaR-II gene is regulated have shown that differentiation of EC cells leads to the transcriptional activation of this gene. Based on work with the promoter region of the human TbetaR-II gene, two hypotheses have emerged. First, the transcription of the TbetaR-II gene is influenced significantly by at least two positive and two negative regulatory regions. Second, the transcription factor complex NF-Y, which binds to one of the negative regulatory elements in the gene, reduces the transcription of the TbetaR-II gene by interfering with the binding or function of transcription factors that bind to neighboring positive regulatory elements. To test these hypotheses, four Specific Aims are proposed: 1) determine which transcription factors interact with one another to regulate the transcription of the TbetaR-II gene, 2) isolate the promoter region of the murine TbetaR-II gene and map precisely the location of the regulatory elements, 3) identify the transcription factors that bind to the regulatory elements of the TbetaR-II gene, and 4) determine whether differentiation of EC cells alters the chromatin structure of the TbetaR-II gene and the binding of transcription factors to critical regulatory elements. Together, Dr. Rizzino feels that these studies will not only help determine how the TbetaR-II gene is regulated normally, but they will also provide the groundwork for understanding why this gene is aberrantly expressed in tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA079491-02
Application #
6124645
Study Section
Pathology B Study Section (PTHB)
Program Officer
Gallahan, Daniel L
Project Start
1998-12-14
Project End
2002-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
2
Fiscal Year
2000
Total Cost
$196,397
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Bernadt, Cory T; Rizzino, Angie (2003) Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes. Mol Reprod Dev 65:353-65
Wilder, Phillip J; Bernadt, Cory T; Kim, Jae-Hwan et al. (2002) Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1. Mol Reprod Dev 63:282-90
Kim, Jae-Hwan; Wilder, Phillip J; Hou, Jingwen et al. (2002) Activation of the murine type II transforming growth factor-beta receptor gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/Ese-1. J Biol Chem 277:17520-30
Nowling, Tamara; Desler, Michelle; Kuszynski, Charles et al. (2002) Transfection of embryonal carcinoma cells at high efficiency using liposome-mediated transfection. Mol Reprod Dev 63:309-17
Johnson, Lance R; Johnson, Teresa K; Desler, Michelle et al. (2002) Effects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300. J Biol Chem 277:4088-97
Kingsley-Kallesen, M; Luster, T A; Rizzino, A (2001) Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells. In Vitro Cell Dev Biol Anim 37:684-90
Wilder, P J; Desler, M M; Nowling, T K et al. (2001) Isolation and characterization of the murine transforming growth factor-beta2 promoter. Gene 270:201-9
Kingsley-Kallesen, M L; Kelly, D; Rizzino, A (1999) Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein. J Biol Chem 274:34020-8